SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is surging as investors capitalize on a growing natural gas supply crisis triggered by conflict in the Middle East and damage to critical energy infrastructure. Community sentiment remains highly bullish, with active discussions focusing on the stock's potential for a short squeeze, its role as a strategic European LNG supplier, and heavy retail accumulation as volume levels continue to climb.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is facing intense backlash and bearish sentiment from investors following the announcement of a reverse stock split, with many in the community viewing the move as a "kiss of death" for the struggling streaming platform. Discussions are heavily focused on the company's lack of key sports networks, dwindling subscriber confidence, and frustration toward leadership, leading many traders to actively initiate or hold short positions.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

The Fundrise Innovation Fund (VCX) is seeing intense volatility and record-high trading volume as retail investors react to its direct exposure to high-profile private AI firms like OpenAI, Anthropic, and SpaceX. While bullish sentiment is driven by the fund's unique access to these sought-after holdings, many market participants are actively debating the sustainability of its current market price compared to its intrinsic net asset value, frequently comparing the situation to previous low-float 'pump and dump' market events.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending as investors digest mixed results from its Phase 3 SENTRY trial in myelofibrosis, which met spleen volume reduction goals but missed on key symptom endpoints. Community discourse is highly polarized, with some highlighting the strong overall survival signal as a potential path for future regulatory success, while others express deep frustration over the company's financial runway and recent private placement deals.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is in focus as investors analyze fresh earnings data and ambitious revenue guidance for the upcoming fiscal year, with the community closely tracking the potential for major contract awards to drive future growth. While market participants debate the stock's valuation and volatility, the primary discussion remains centered on whether the company's long-term backlog and infrastructure projects can offset short-term execution risks.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as a highly speculative, low-cap meme coin that has polarized the community, with some traders touting its potential for explosive gains while others warn it is a classic pump-and-dump scheme. Discussion centers on its rapid price volatility, accessibility via DEX platforms, and ongoing debate over whether its current price action reflects genuine accumulation or manipulative tactics by top holders.

Cantor Equity Partners II, Inc. is a blank check company. The company was founded on November 11, 2020 and is headquartered in New York, NY

Cantor Equity Partners II Inc. - Ordinary Shares - Class A

Cantor Equity Partners II Inc

Investors are closely tracking Cantor Equity Partners II as it nears its business combination with Securitize, the infrastructure provider behind major institutional tokenization projects like BlackRock's BUIDL fund. Market participants are treating the stock as a pure-play opportunity for the real-world asset (RWA) tokenization sector, with many discussing the long-term growth potential and institutional backing from major financial players.

Smithfield Foods, Inc. operates as a meat-processing company. The firm processes and produces pork and hog. Its brands include Smithfield, Eckrich, Nathan's Famous, Farmland, and Armour. The company was founded by Joseph Williamson Luter, Sr. and Joseph Williamson Luter, Jr. in 1936 and is headquartered in Smithfield, VA.

Smithfield Foods, Inc.

Smithfield Foods Inc.

Smithfield Foods is trending as investors react to the companys recent earnings beat, which showcased strong growth in the packaged meats segment and a dividend increase. The community is actively discussing the stock's long-term potential, including its recent acquisition of Nathan's Famous and its strategic positioning in the protein sector despite ongoing debates surrounding industry ownership.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as investors monitor the early commercial rollout of Yartemlea following recent FDA approval, with community discussions heavily focused on patient population penetration and revenue ramp-up potential. The stock remains a focal point for debate over institutional short positioning versus long-term value, as stakeholders look toward upcoming earnings and international regulatory progress for catalysts.

NETGEAR, Inc. engages in the provision of networking technologies for businesses, homes, and service providers. It operates through the Connected Home and NETGEAR for Business segments. The Connected Home segment offers WiFi networking solutions such as 4G/5G mobile products, WiFi 7 Tri-band and Quad-band mesh systems and routers, WiFi 6E, WiFi 6, and subscription services. The NETGEAR for Business segment consists of networking solutions, including switches, routers, access points, software, and AV over IP technologies. The company was founded by Patrick C. S. Lo and Mark G. Merrill on January 8, 1996, and is headquartered in San Jose, CA.

Netgear Inc

Netgear is seeing significant market attention as U.S. regulators take action against foreign-made routers, fueling community discussion regarding the company's competitive standing and potential market share gains. While traders debate the stock's turnaround potential and its exposure to ongoing supply chain and geopolitical risks, some investors are highlighting the company's valuation relative to its cash position as a key point of interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CAUD investors: 
If you want to know what you’re in for or what to expect… look at $GOLQ. That’s your blueprint and that’s your end game. 
When the stock price continues to plummet, they’ll keep your shares restricted and blame naked shorts. You will never see a dime of those. Those shares all become available to trade and all value goes away. 
How do they expect to acquire anyone at .50 c a share? 5-10mill shares issued every acquisition? More value down the drain. You’re a sucker if you were sold on the business model but it’s not too late to salvage some value.

StockTwits for iOS

Abri SPAC I Inc

GoLogiq Inc

 investors: 
If you want to know what you’re in for or what to expect… look at 

. That’s your blueprint and that’s your end game. 
When the stock price continues to plummet, they’ll keep your shares restricted and blame naked shorts. You will never see a dime of those. Those shares all become available to trade and all value goes away. 
How do they expect to acquire anyone at .50 c a share? 5-10mill shares issued every acquisition? More value down the drain. You’re a sucker if you were sold on the business model but it’s not too late to salvage some value.